货号：UP535018346
| 产品信息 | |
| 产品名称： | TMC353121 |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 857066-90-1 |
| 分子式： | C32H42N6O3 |
| 分子量： | 558.71 |
| MDL NO： | - |
| 标准纯度： | 98+% (UP535018346) |
| 沸点： | - |
| 储存： | (UP535018346) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
BOC-D-FMK
UP636768664634911-80-1
Desacetylcinobufotalin
UP4062656744099-30-3
MK-0893
UP934606238870823-12-4
(2-Methylprop-1-en-1-yl)benzene
UP656371739768-49-0
(R)-2-((Benzyloxy)methyl)oxirane
UP38921423414618-80-5
Z-VAD-FMK
UP707268165161401-82-7
1-Bromo-4-iodo-5-methyl-2-nitrobenzene
UP7445814901160573-63-6
USP7-IN-1
UP8906445501381291-36-6
(4R,5S)-4-Hydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one
UP12962708738996-14-4
Medroxyprogesterone Acetate
UP66748055671-58-9
Doxercalciferol
UP52696175654573-75-0
tert-Butyl 2-cyanoacetate
UP9851883371116-98-9
Chlorocyclopentadienylbis(triphenylphosphine)ruthenium(II)
UP60771040232993-05-8
Methyl 2-(dimethoxyphosphoryl)acetate
UP3604545115927-18-4
(7R,8R,9S,13S,14S,17S)-13-Methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-
UP220892961153004-31-0
BLU-554
UP3989868711707289-21-1
3-Nitrobenzenesulfonic acid hydrate
UP90546124179326-96-8
4-Bromo-6-fluoro-1H-indazole
UP777146741885520-35-4
Omarigliptin
UP1682033611226781-44-7
BIO
UP356439494667463-62-9
4-Bromo-N-thiomorpholinobenzenesulfonamide
UP776732620223555-81-5
5-Bromo-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine
UP342409254858116-66-2
EHop-016
UP2548159321380432-32-5
LX1606
UP7060526061033805-22-9
Ranirestat
UP821200057147254-64-6
2,4-Thiazolidinedione
UP2129996702295-31-0
1-Phenylpyrazole-4-sulfonic acid
UP74975675418336-36-2
BIX-02189(Random Configuration)
UP4780164191094614-85-3
Sulcotrione
UP77806922499105-77-8
PI4KIIIbeta-IN-10
UP8708546791881233-39-1
RG7112
UP164978194939981-39-2
2,2-Diphenylacetyl chloride
UP9498097461871-76-7
Bis[1,2-bis(diphenylphosphino)ethane]palladium(0)
UP34685559731277-98-2
GSK2578215A
UP4826469961285515-21-0
4-Chloroisothiazole-5-carboxylic acid
UP74413514488982-87-0
Diphenylsilanediol
UP920377837947-42-2
4,6-Difluoroindolin-2-one
UP569534700247564-57-4
T0901317
UP353272953293754-55-9
GSK690693
UP190221600937174-76-0
1,2-Bis(4-(5-methylbenzo[d]oxazol-2-yl)phenyl)ethene
UP61237360222397-00-4
Brivanib
UP907500456649735-46-6
Diethyl 2-propyl-1H-imidazole-4,5-dicarboxylate
UP131034291144689-94-1
I-BET-151
UP9178661391300031-49-5
Perifosine
UP957943667157716-52-4
(3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one
UP60477984315384-37-9
CRAC intermediate 2
UP184995606123066-64-8
Altrenogest
UP651514921850-52-2
2-(7-Hydroxy-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid
UP49076278815852-10-8
Carbazochrome
UP62127743069-81-8
3-Fluoro-4-methoxybenzene-1-sulfonyl chloride
UP75997930467475-55-2
Butane-1,4-disulfonic acid hydrate
UP9337853751588441-14-8
BMS-5
UP2609299311338247-35-0
(Z)-Methyl 3-amino-4-(2,4,5-trifluorophenyl)but-2-enoate
UP819295186881995-70-6
ONO-4059 analog
UP6466303171351635-67-0
Levonorgestrel
UP875508033797-63-7
Chelerythrine Chloride
UP2404076103895-92-9
VX-765
UP806115835273404-37-8
TMC353121
UP535018346857066-90-1